Key Highlights

  • Onterris shares are down 24.88% in pre-market trading.
  • Q2 2026 revenue reached $186.7 million, down 20.4% year over year and about 6% below Wall Street estimates.
  • Full-year 2026 revenue guidance was slashed to $840 to $900 million from prior guidance of $958 million.
  • Adjusted EBITDA guidance was cut to $190 to $210 million versus $251.5 million previously.
  • Investors are also digesting a surprise announcement of a Board-led strategic review of the company's portfolio and capital allocation.

Shares Sink on Steep Guidance Cut

Onterris (NYSE:ONT) is trading sharply lower today, extending after-hours weakness, after the environmental services company reported second-quarter revenue that fell short of Wall Street estimates and slashed its full-year outlook. Shares fell as much as 24.88% to $17.00 in pre-market trading, adding to a 0.96% decline in the prior regular session.

Onterris, formerly known as Montrose Environmental Group, is a leading environmental solutions company headquartered in North Little Rock, Arkansas, operating across the United States, Canada, and Australia. The company serves clients through two core segments, Consulting and Advisory and Treatment and Measurement and Analysis, offering services such as environmental consulting, regulatory permitting, toxicology advisory, emergency response, and engineering solutions for contaminated water and air remediation, alongside comprehensive air and soil testing and laboratory services.

Guidance Slashed Amid Weak Demand

Second-quarter revenue of $186.7 million was down 20.4% year over year and about 6% below Wall Street estimates, boosted by a single large project. Despite the environmental services provider beating its own previously reduced Q2 revenue and EBITDA guidance, full-year 2026 revenue guidance was slashed to $840 to $900 million, well below $958 million consensus, and cut EBITDA guidance to $190 to $210 million versus $251.5 million expected.

Investors are also digesting the surprise announcement of a Board-led strategic review of the company's business, portfolio, and capital allocation strategy. The announcement of a strategic review alongside a poison pill rights plan suggests activist investor pressure may be building around the stock, even as the guidance cut has overshadowed the strategic review news in today's trading.

The company's diverse customer base spans industrial, utilities, government, and industrial manufacturing sectors, providing consulting, regulatory permitting, toxicology advisory, and emergency response services alongside its testing and treatment offerings. Management has previously highlighted long-term secular tailwinds tied to increasing environmental regulatory complexity, though near-term demand softness across state and local government contracts appears to be weighing more heavily on results than these longer-term growth drivers.

Conclusion

Onterris' sharp decline reflects both a significant guidance cut driven by weaker demand trends and uncertainty introduced by the newly announced strategic review of the company's portfolio. Investors will likely watch for further details on the review's scope and timeline as the company navigates a challenging demand environment.

This article is for informational purposes only and does not constitute financial, investment, or trading advice. Readers should conduct their own research or consult a licensed financial advisor before making any investment decisions.